Computer-Aided Drug Design: Current Approaches, Challenges, and Future Perspectives
Computer-aided drug design (CADD) is an important computational approach in modern drug discovery and development. Conventional drug discovery is time-consuming, costly, and complex, with a high risk of failure. CADD supports the identification, design, evaluation, and optimization of potential drug candidates through computational tools and molecular modelling techniques. This review outlines the principal methods, applications, advantages, limitations, and recent advances in CADD. It discusses the two major approaches—structure-based drug design (SBDD) and ligand-based drug design (LBDD)—along with molecular docking, virtual screening, quantitative structure–activity relationship (QSAR) analysis, pharmacophore modelling, molecular dynamics simulation, de novo drug design, and ADMET prediction. These methods can support target identification, hit discovery, lead optimization, drug repurposing, and the early assessment of pharmacokinetic and toxicity-related properties. The review also considers the growing role of artificial intelligence (AI) and machine learning (ML) in predicting molecular properties, prioritizing candidate compounds, and informing drug-design strategies. Despite their potential, CADD methods face challenges involving data quality, prediction accuracy, computational demands, and model validation. Experimental studies therefore remain essential to confirm the biological activity, safety, and therapeutic potential of computationally predicted compounds. Overall, integrating CADD with experimental research may improve the efficiency of drug discovery and pharmaceutical development.
Authors
- Samiksha Patil
- Tejas Kakad
- Suraj Rajurkar
- Aditya Rudarkar
- Palak Shende
- Bhushan Pote
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-21
- DOI
- https://doi.org/10.5281/zenodo.24414541
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00